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Introduction {#sec1-1}
============

Spinal cord injury (SCI) involves serious damage to the central nervous system and is dysfunctional in nature (Simon et al., 2019; Yao et al., 2019). The latest research shows that approximately 2.5 million people have varying degrees of SCI, and each year there are more than 130,000 new cases (Thuret et al., 2006). SCI mainly results from traffic trauma, fall injury, work accidents, violence, or sports injuries. To recover from incomplete damage, some sensory neurons can undergo a variety of physical rehabilitative treatments to restore function (Waters et al., 1991; Crozier et al., 1992). SCI prevention, treatment, and rehabilitation of injuries have become a major medical concern. Approximately 20% of patients with spinal fractures have varying degrees of SCI. Currently, treatment of SCI mainly includes drugs, surgery, and immobilization. Treatment methods are chosen according to the severity of the illness, length of the injury, effectiveness of the treatment, and the pathological stage of the specific case. At present, there is no operative treatment to recover lost neurological function after SCI (Cristante et al., 2012; Wei et al., 2019).

MicroRNAs (miRNAs), a class of endogenous small RNAs approximately 20--24 nucleotides in length, have a variety of important regulatory roles in cells. Each miRNA can have multiple target genes, and several miRNAs can regulate the same gene. This complex regulatory network can regulate the expression of multiple genes through a single miRNA, or can finely regulate the expression of a gene through a combination of several miRNAs. It is speculated that miRNAs regulate one-third of human genes. Recent studies have shown that approximately 70% of mammalian miRNAs are located in the regions of transcriptional units (transcription micro RNA; Rodriguez et al., 2004), and most are located within introns (Kim and Nam, 2006). The location of some intronic miRNAs is highly conserved among different species. MiRNAs are not only conserved at gene positions, but also exhibit high sequence homology (Grishok et al., 2001; Lee and Ambros, 2001). MicroRNA-21 (miR-21) not only plays an important role in fibrotic lung diseases, but is also part of an innovative miRNA-based therapeutic method to treat clinically refractory fibrotic diseases, such as idiopathic pulmonary fibrosis. According to our previous research, miR-21 knockdown pointedly upgraded the recovery of motor function after SCI and inhibited neural regeneration, which was suppressed in the miR-21 knockdown group (Wang et al., 2018b). In this study, we used a proteomics approach to understand the status of different proteins in negative control (NC) and miR-21a-5p-knockdown (KD) groups, as well as their interactions and roles after SCI in a mouse model.

Materials and Methods {#sec1-2}
=====================

Animals and SCI models {#sec2-1}
----------------------

Eighteen C57BL/6 adult male mice (aged 9--10 weeks) were provided by the Animal Center of Shandong University, China. All mice were maintained in individual cages under controlled conditions of 22--24°C and relative humidity of 40--60%, with a 12-hour light/dark cycle and free access to food and water. All experimental procedures and protocols were approved by the Experimental Animal Ethics Committee of Shandong University of China on March 5, 2014. The experimental procedure followed the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996).

Mice were intraperitoneally anesthetized with 10% chloral hydrate (3 mg/kg; Merck, Rahway, NJ, USA). Laminectomy was performed at T8--10 of the thoracic vertebra without any SCI. A moderate collision injury was caused by a modified Allen's weight drop apparatus (8-g weight at 50 mm, 8 g × 50 mm) knocking on the exposed spinal cord (Liu et al., 2018). The sham group was only subjected to laminectomy without the collision injury.

Treatment of animals {#sec2-2}
--------------------

A total of 18 mice were randomly divided into NC and KD groups. In the NC group (*n* = 9), mice were subjected to SCI and treated with miR-21 NC (RiboBio, Guangzhou, China) at 55 μL/d, 95 nmol/mL (intraspinal injection) for 3 days. In the KD group (*n* = 9), mice were subjected to SCI and treated with antagomir-21 (intraspinal injection; RiboBio, Guangzhou, China) for 3 days. The markers of successful model establishment included systolic tremor, local edema and congestion, and dural integrity (Liu et al., 2018; Wang et al., 2018). Subsequently, mice were sacrificed, and the injured T8--10 regions of spinal cord were stored in liquid nitrogen.

Protein preparation {#sec2-3}
-------------------

Total protein was extracted from spinal cord samples harvested from the site of injury using cell lysate buffer containing 1 mM phenylmethane sulfonyl fluoride and a protein phosphatase inhibitor (Solarbio Life Sciences, Beijing, China). Protein was isolated after washing, crushing, lysis of cells, and finally centrifugation. After protein concentrations were calculated with a NanoDrop spectrometer (Thermo Fisher Scientific, Waltham, MA, USA), protein samples were ready for further processing.

Preparation of samples for liquid chromatography tandem mass spectrometry {#sec2-4}
-------------------------------------------------------------------------

For preparation of samples for liquid chromatography tandem mass spectrometry (LC-MS/MS) sample preparation, we performed an in-solution (trypsin) digestion protocol as previously described by Anwar et al. (2019) with minor modification. After trypsin digestion, peptide purification was attained by Ziptip (Millipore, Billerica, MA, USA) as previously described (Zachara et al., 2011).

Data processing and parameters {#sec2-5}
------------------------------

A high-resolution tandem mass spectroscopy system (NanoLC-Ultra 2D Plus with LTQ Orbitrap Velos Pro, Thermo Fisher Scientific) was used for analysis and data processing of digested peptides. Three biological replicates were prepared for each sample using previously described parameters (Anwar et al., 2019). Raw files from LC-MS were transferred into the built-in Proteome Discoverer software 1.3 (Thermo Fisher Scientific) and searched using the Mascot search engine against mouse proteome sequence databases for data processing. Parameters were adjusted as: (a) in trypsin digestion, with two maximum missed cleavage points permitted; (b) length of the digested peptide: 6--144; (c) precursor mass tolerance of 10 ppm and fragment mass tolerance adjusted to 0.8 Da; (d) in dynamic variation oxidation of methionine and in static modification carbamidomethyl of cysteine were selected; and (e) the false discovery rate rationale was based on *q*-value \< 0.01. The level of peptide confidence for the data filter was adjusted to "high".

Statistical analysis {#sec2-6}
--------------------

DAVID 6.8 (<https://david.ncifcrf.gov/>), DAVID 6.7 (<https://david-d.ncifcrf.gov/>), and KOBAS 3.0 (<http://kobas.cbi.pku.edu.cn/>) online databases were used for KEGG pathway and protein clustering analyses. Statistical analysis was performed using GraphPad Prism Version 6.01 software (GraphPad, San Diego, CA, USA). Data are expressed as the mean ± SD and Log2 Fold Change (Log2FC). Gene Ontology (GO) of all proteins was observed via online protein ontology database. Student's *t*-test was used for statistical significance. A P-value \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

Up- and downregulated proteins in NC and KD groups {#sec2-7}
--------------------------------------------------

Proteomics evaluation revealed the presence of 267 common proteins in NC and KD groups, as well as 65 and 127 unique proteins in NC and KD groups, respectively (**[Figure 1A](#F1){ref-type="fig"}**).

![Overall proteome and GO slim between KD and NC groups.\
(A) Venn diagram of total proteins in NC and KD groups: Only common proteins were selected from both biological repeats of NC and KD groups, and then further compared with each other using a Venn diagram. A total of 267 common proteins were present in both NC and KD groups, while 127 proteins were unique to the KD group and 65 proteins were unique to the NC group. (B) GO slim of KD and NC groups: the top six gene ontologies of all three categories are presented. miR-21a-5p was involved functions of all three categories (molecular function, cellular component, and biological processes). GO: Gene Ontology; KD: knockdown; NC: negative control.](NRR-15-1102-g002){#F1}

The ontologies of all proteins from KD and NC groups (394 and 332, respectively) were evaluated via online protein ontology database. Within GO slim, three domains were identified: molecular function, biological process and cellular component, and molecular function. Within molecular function, most proteins were involved in the binding of ions, proteins, and drugs. Within cellular components, several proteins were involved in various components, such as cell parts, cytoplasm, and protein coating complex. For biological process, we found proteins involved in developmental process, multicellular organismal process, and cell communication (**[Figure 1B](#F1){ref-type="fig"}**).

Among all proteins from KD and NC groups (394 and 332, respectively), we identified significantly differentially expressed proteins on the bases of coverage. Our results revealed that different proteins were significantly upregulated in the KD group, such as protein S100-A8, acyl-CoA-binding proteins, peroxiredoxin-1, vimentin, phosphoglycerate kinase 1, and translationally controlled tumor protein (**[Table 1](#T1){ref-type="table"}** and **[Figure 2](#F2){ref-type="fig"}**).

###### 

Up-regulated proteins in the knockdown and negative control groups

  Protein ID   Description                                Gene ID      Coverage (mean value)   Difference (fold change)   *P*-value   
  ------------ ------------------------------------------ ------------ ----------------------- -------------------------- ----------- --------
  P27005       Protein S100-A8                            *S100a8*     87.64                   41.02                      2.14        0.0617
  D3Z563       Acyl-CoA-binding protein                   *Dbi*        77.78                   0                          N.A         N.A
  P35700       Peroxiredoxin-1                            *Prdx1*      73.62                   42.46                      1.73        0.0326
  P20152       Vimentin                                   *Vim*        71.78                   57.83                      1.24        0.2971
  P09411       Phosphoglycerate kinase 1                  *Pgk1*       71.58                   68.71                      1.04        0.2025
  P09528       Ferritin heavy chain                       *Fth1*       67.31                   50.83                      1.32        0.1714
  P63028       Translationally-controlled tumor protein   *Tpt1*       67.74                   56.11                      1.21        0.0946
  Q91VW3       SH3BGR glutaredoxin                        *Sh3bgrl3*   56.99                   0                          N.A         N.A
  Q9QUH0       Glutaredoxin-1                             *Glrx*       53.27                   39.72                      1.34        0.0473

![Up- and downregulated proteins in the KD group.\
(A) Several proteins, such as S100-A8, acyl-CoA-binding proteins, peroxiredoxin-1, and vimentin, were upregulated in the KD group compared with the NC group. S100-A8 plays a prominent role in the regulation of inflammatory processes, immune response, and antioxidant activity. We found that protein levels of both S100-A8 and S100-A9 were upregulated two-fold in the KD group compared with the NC group. (B) Alpha-1-antitrypsin 1-1, 1-2, 1-4, and 1-5, along with stathmin and neurofilaments (medium and heavy), were downregulated in the KD group compared with the NC group. KD: Knockdown; NC: negative control.](NRR-15-1102-g003){#F2}

Protein S100-A8, an S100 family member that acts as a calcium-binding protein with antioxidant activity (Choi et al., 2014), was previously reported to play a role in tumor-stromal interactions and arthritis as a pro-inflammatory factor (Kane et al., 2003; Basso et al., 2014). Migration inhibitory factor-related proteins 8 (MRP8) and 14 (MRP14), two binding proteins highly present in neutrophils that influence macrophages (Odink et al., 1987; Pechkovsky et al., 2000; Ryckman et al., 2003), are used as biomarkers to detect autoimmune diseases and inflammation in bacterial infections (Frosch et al., 2000; Pechkovsky et al., 2000; Ryckman et al., 2003). These proteins, which belong to the family of damage-associated molecular pattern molecules, play a role in protection against oxidative tissue damage. During inflammation, excessive oxidative modifications of S100-A8 and S100-A9 eliminate their chemotactic characteristics; this restrains leukocyte conscription and turns off inflammation (Lim et al., 2011).

Peroxiredoxins (PRDXs) are immune modulators that belong to a ubiquitous family of antioxidant enzymes (Pylvas et al., 2010). In prokaryotes and eukaryotes, PRDXs are present in cytosol, whereby they have a significant role in various signaling pathways, as well as influence over many other biological activities of cells, such as immune response, differentiation, proliferation, apoptosis, oxidation-sensitive protein protection, redox signaling, and regulation of cellular H~2~O~2~ (Kang et al., 1998; Seo et al., 2000; Rhee et al., 2005; Cong et al., 2018). PRDX1 also plays a role in the recovery of SCI. Upregulation of PRDX1, which is directly associated with fibroblast growth factor 1, regulates the level of reactive oxygen species and autophagy during SCI. In addition, PRDX1 reportedly has a main role in astrocyte and microglia proliferation after SCI (Huang et al., 2015; Li et al., 2018). Our proteomics results suggested that knockdown of miR-21a-5p increases PRDX expression, which is helpful in the recovery of SCI. Vimentin is a class-III intermediate and intracellular filament protein with important roles in various cellular processes, such as migration and adhesion (Eckes et al., 1998; Tsuruta and Jones, 2003; Ivaska et al., 2007). Extracellular vimentin plays a role in SCI recovery by increasing axonal growth activity and motor function. Indeed, through several signaling factors in neurons, vimentin works like a neurotrophic factor or adhesive factor (Shigyo and Tohda, 2016). We also confirmed through western blot assay that knockdown of miR-21a-5p upregulated the expression level of vimentin compared with NC. In contrast, stathmin was downregulated after miR-21a-5p knockdown (data not shown).

Protease inhibitors represent a highly significant mechanism for the regulation of proteolytic activity. Serpins, a vast family of proteins with a conserved structure, have been found across different domains, including animals, viruses, plants, bacteria, and archaea (Silverman et al., 2001; Roberts et al., 2004). Vertebrate serpins are part of essential biological processes such as inflammation, blood coagulation, angiogenesis, and tumor inhibition (van Gent et al., 2003). In the KD group, alpha-1-antitrypsin was downregulated. A detailed description of these proteins is listed in **[Table 2](#T2){ref-type="table"}**.

###### 

Down-regulated proteins in the knockdown and negative control groups

  Protein ID   Description                       Gene ID       Coverage (mean value)   Difference (fold change)   *P*-value   
  ------------ --------------------------------- ------------- ----------------------- -------------------------- ----------- --------
  P07309       Transthyretin                     *Ttr*         42.52                   64.97                      1.53        0.3469
  P22599       Alpha-1-antitrypsin 1-2           *Serpina1b*   26.51                   42.74                      1.61        0.9686
  P07758       Alpha-1-antitrypsin 1-1           *Serpina1a*   29.18                   37.53                      1.29        0.0678
  Q00897       Alpha-1-antitrypsin 1-4           *Serpina1d*   28.33                   37.78                      1.33        0.0637
  Q00898       Alpha-1-antitrypsin 1-5           *Serpina1e*   22.16                   34.02                      1.54        0.254
  A0A0R4J036   Neurofilament 3, medium           *Nefm*        49.53                   81.5                       1.65        0.0112
  P19246       Neurofilament heavy polypeptide   *Nefh*        27.11                   50.78                      1.87        0.0317
  P54227       Stathmin                          *Stmn1*       0                       47.65                      N.A         N.A

Neurofilaments are typically comprised of three intermediary filament proteins: light (NefL), medium (NefM), and heavy (NefH), which play a role in neuronal caliber. In addition, NefH has a vital role in mature axons that is not sub-served by the two smaller neurofilaments proteins (Laser-Azogui et al., 2015). After knockdown of miR-21a-5p, NefH and NefM were downregulated.

Data consist of unique proteins that appear only in the NC and KD groups, along with their sub-cellular localizations and biological functions {#sec2-8}
----------------------------------------------------------------------------------------------------------------------------------------------

We analyzed data from both groups and identified unique proteins in each group of samples (**[Figure 3](#F3){ref-type="fig"}**). From the first group of MS/MS data, we found 467 proteins in NC-1 and 548 proteins in KD-1. A total of 327 common proteins were identified between samples, as well as 140 unique proteins in NC-1 and 221 unique proteins in KD-1 (**[Figure 3](#F3){ref-type="fig"}**). From the second group of MS/MS data, 594 and 587 proteins were found from NC-2 and KD-2, respectively, with 419 common proteins between these samples, and 175 and 168 unique proteins in NC-2 and KD-2, respectively (**[Figure 3](#F3){ref-type="fig"}**).

![Identified proteins down- or upregulate in a mouse spinal cord injury model with knockdown of miR-21a-5p.\
Venn diagrams of enriched proteins identified in both NC and KD groups. There were 221 and 140 unique proteins identified in KD-1 and NC-1, respectively; whereas, 168 and 175 proteins were identified in KD-2 and NC-2, respectively. We identified 28 proteins in both KD-1 and KD-2 (KD only), as well as 21 proteins in both NC-1 and NC-2 (only NC). A list of these proteins is presented within the boxes (only KD and only NC) as their gene names. KD: Knockdown; NC: negative control.](NRR-15-1102-g004){#F3}

Subsequently, we compared unique proteins in NC-1 and NC-2 samples, as well as KD-1 and KD-2 samples. We found two common proteins between NC-1 and NC-2 unique proteins, and 28 common proteins between KD-1 and KD-2. These results suggested that 21 proteins are only present in the NC group (**[Table 3](#T3){ref-type="table"}**). Similarly, 28 proteins were only present in the KD group (**[Table 4](#T4){ref-type="table"}**).

###### 

List of unique proteins present only in the negative control group

  Protein AC   Protein name                                                              Gene name                   Pfam name                                                                                          Product size (bp)
  ------------ ------------------------------------------------------------------------- --------------------------- -------------------------------------------------------------------------------------------------- -------------------
  O88844       Isocitrate dehydrogenase \[NADP\] cytoplasmic                             *Idh1*                      Isocitrate/isopropylmalate dehydrogenase                                                           414
  P06837       Neuromodulin                                                              *Gap43; Basp2*              IQ calmodulin-binding motif; Neuromodulin; Gap junction protein N-terminal region                  227
  P26350       Prothymosin alpha                                                         *Ptma*                      Prothymosin/parathymosin family                                                                    111
  P28667       MARCKS-related protein                                                    *Marcksl1; Mlp, Mrp*        MARCKS family                                                                                      200
  P53994       Ras-related protein Rab-2A                                                *Rab2a; Rab2*               Ras family                                                                                         212
  P54227       Stathmin                                                                  *Stmn1; Lag, Lap18, Pr22*   Stathmin family                                                                                    149
  P62073       Mitochondrial import inner membrane translocase subunit Tim10             *Timm10; Tim10*             Tim10/DDP family zinc finger                                                                       90
  P70195       Proteasome subunit beta type-7 precursor                                  *Psmb7; Mmc14*              Proteasome subunit; Proteasome beta subunits C terminal                                            277
  Q6W8Q3       Purkinje cell protein 4-like protein 1                                    *Pcp4l1*                                                                                                                       68
  Q8VCM7       Fibrinogen gamma chain precursor                                          *Fgg*                       Fibrinogen beta and gamma chains, C-terminal globular domain; Fibrinogen alpha/beta chain family   436
  Q8VDQ8-2     Isoform 2 of NAD-dependent protein deacetylase sirtuin-2                  *Sirt2*                                                                                                                        
  Q91WK5       Glycine cleavage system H protein, mitochondrial precursor                *Gcsh*                      Glycine cleavage H-protein                                                                         170
  Q9D6R2       Isocitrate dehydrogenase \[NAD\] subunit alpha, mitochondrial precursor   *Idh3a*                     Isocitrate/isopropylmalate dehydrogenase                                                           366
  Q9WTQ5-2     Isoform 2 of A-kinase anchor protein 12                                   *Akap12*                                                                                                                       
  Q9JJV2       Profilin-2                                                                *Pfn2*                      Profilin                                                                                           140
  A1BN54       Alpha actinin 1a                                                          *Actn1; Actn1a*             Calponin homology; Spectrin repeat;                                                                887
  A2AKN9       Major urinary protein 2                                                   *Mup2; Mup4*                Lipocalin / cytosolic fatty-acid binding protein family                                            180
  B1AXW3       Aldo-keto reductase family 1 member A1                                    *Akr1a1*                    Aldo/keto reductase family                                                                         203
  E0CZA1       T-complex protein 1 subunit epsilon                                       *Cct5*                      TCP-1/cpn60 chaperonin family                                                                      199
  F6UFG6       Acidic leucine-rich nuclear phosphoprotein 32 family member A             *Anp32a*                    Leucine-rich repeat                                                                                138
  J3QP71       Basigin                                                                   *Bsg*                                                                                                                          197

###### 

List of unique proteins present only in the knockdown group

  Protein AC   Protein name                                                                 Gene name              Pfam name                                                                         Product size (bp)
  ------------ ---------------------------------------------------------------------------- ---------------------- --------------------------------------------------------------------------------- -------------------
  O35737       Heterogeneous nuclear ribonucleoprotein H                                    *Hnrnph1; Hnrph*       RNA recognition motif                                                             449
  O54724       Caveolae-associated protein 1                                                *Cavin1; Ptrf*         PTRF/SDPR family                                                                  392
  O70251       Elongation factor 1-beta                                                     *Eef1b; Eef1b2*        EF-1 guanine nucleotide exchange domain                                           225
  P07361       Alpha-1-acid glycoprotein 2 precursor                                        *Orm2; Agp-2, Orm-2*   Lipocalin / cytosolic fatty-acid binding protein family                           207
  P08207       Protein S100-A10                                                             *S100a10; Cal1l*       S-100/ICaBP type calcium binding domain                                           97
  Q6NXH9       Keratin, type II cytoskeletal 73                                             *Krt73; Kb36*          Intermediate filament protein                                                     539
  Q8BGZ7       Keratin, type II cytoskeletal 75                                             *Krt75; Kb18*          Intermediate filament protein; Keratin type II head                               551
  Q9D2P8-4     Isoform 4 of Myelin-associated oligodendrocyte basic protein                 *Mobp*                                                                                                   
  Q8C522       Endonuclease domain-containing 1 protein precursor                           *Endod1*                                                                                                 501
  Q9CR16       Peptidyl-prolyl cis-trans isomerase D                                        *Ppid*                 Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD                          370
  Q9D6R2-2     Isoform 2 of Isocitrate dehydrogenase \[NAD\] subunit alpha, mitochondrial   *Idh3a*                                                                                                  
  Q9DB05       Alpha-soluble NSF attachment protein                                         *Napa; Snapa*          Soluble NSF attachment protein, SNAP                                              295
  Q9Z2I0       Mitochondrial proton/calcium exchanger protein precursor                     *Letm1*                LETM1-like protein                                                                738
  A2A6F8       60S ribosomal protein L23                                                    *Rpl23*                                                                                                  60
  A2AKV0       ATP synthase                                                                 *Atp5c1*               ATP synthase                                                                      101
  A2AVJ7       Ribosome-binding protein 1                                                   *Rrbp1*                Ribosome receptor lysine/proline rich region                                      1464
  B1AT92       Growth factor receptor-bound protein 2                                       *Grb2*                 SH2 domain; SH3 domain                                                            203
  D3Z563       Acyl-CoA-binding protein                                                     *Dbi*                  Acyl CoA binding protein                                                          63
  E9QMV2       Costars family protein ABRACL                                                *Abracl*               Costars                                                                           81
  F6RDR0       Alpha-adducin (Fragment)                                                     *Add1*                                                                                                   160
  F6SVV1       40S ribosomal protein S7                                                     *Gm9493*               Ribosomal protein S7e                                                             192
  F6VQ81       Tumor protein D54 (Fragment)                                                 *Tpd52l2*              Tumour protein D52 family                                                         161
  F7BNZ5       Breast carcinoma-amplified sequence 1 homolog                                *Bcas1*                                                                                                  379
  G3UWN9       Proteasome activator complex subunit 1 (Fragment)                            *Psme1*                Proteasome activator pa28 alpha subunit; Proteasome activator pa28 beta subunit   173
  Q9WUK2-2     Isoform short of eukaryotic translation initiation factor 4H                 *Eif4h*                                                                                                  
  H7BX22       Ran-specific GTPase-activating protein                                       *Ranbp1*               RanBP1 domain                                                                     153
  Q6ZWQ5       Sorting nexin 12                                                             *Snx12*                PX domain                                                                         162
  Q7TSG6       Radixin                                                                      *Rdx*                  FERM central domain                                                               389

Interactions between unique proteins that appeared only in KD and NC groups were next examined using the STRING database (v11). We found that protein-protein interactions between proteins that only appeared in the KD group showed a strong interaction for myelin sheath and acetylation (**[Figure 4](#F4){ref-type="fig"}**). For proteins that only appeared in the NC group, the protein-protein interaction showed a strong interaction with cytoskeletal binding proteins. This interaction network also showed that miR-21a-5p knockdown induced unique protein expression compared with the NC group. As mentioned above, these unique proteins have strong interactions for myelin sheath, indicating that miR-21a-5p--KD may be helpful to recover myelin in various scleroses.

![Protein-protein network interactions present only in NC or KD groups.\
For the KD group, 24 various proteins were inserted into the STRING online database (version \#11) to examine protein-protein interactions; 24 nodes and 8 edges were achieved for this interaction, with a protein-protein interaction enrichment *P*-value of 0.05. Network nodes represent proteins. Colored lines connecting nodes correspond to types of proof used in calculation: green represents neighborhood evidence, bright blue indicates database evidence, red indicates fusion evidence, black represents co-expression evidence, purple represents experimental proof, blue indicates co-occurrence evidence, and yellow represents text-mining evidence. For the KD group, blue spheres represent acetylation, red spheres represent proteins that play a role in the myelin sheath, and green spheres represent keratin type II. In total, 21 unique proteins from the NC group were inserted into the STRING online database to identify protein-protein interactions; 19 nodes and 6 edges of protein-protein were achieved for this interaction, with an enrichment *P*-value of 0.01. Blue spheres represent protein binding, while red spheres symbolize cytoskeletal protein binding. KD: Knockdown; NC: negative control.](NRR-15-1102-g005){#F4}

Cellular and molecular functions of proteins are shown in **[Figure 5](#F5){ref-type="fig"}**. In both NC and KD groups, cytoplasmic proteins were detected. Others were classified into endoplasmic reticulum, mitochondria, and nucleus (**Figure [5A](#F5){ref-type="fig"}** and **[B](#F5){ref-type="fig"}**). Although a similar distribution was observed in both groups, there was a difference in the biological functions of proteins. A few proteins, such as nucleic acid binding and amide binding, were found only in the KD group (**[Figure 5C](#F5){ref-type="fig"}**), whereas those related to lipid binding, chromatin binding, and transporter activity were only found in the NC group (**[Figure 5D](#F5){ref-type="fig"}**).

![Subcellular localization and functional distribution of unique proteins present only in KD (A and C) and NC (B and D) groups.\
KD: Knockdown; NC: negative control.](NRR-15-1102-g006){#F5}

In the second part of our analysis, we examined the potential role of miR-21a-5p in different pathways and potential correlation with the NC group. According to analysis via ShinyGO v0.50, DAVID database, and KOBAS 3.0, we found various KEGG pathways in which unique proteins of the KD group played a significant role, such as Huntington's disease, Parkinson's disease, carbon metabolism, and oxidative phosphorylation. Proteins highly enriched in the KD group are shown in **[Figure 6](#F6){ref-type="fig"}**. After knockdown of miR-21a-5p, we found that expression levels of proteins associated with key eurodegenerative diseases such as Huntington's, Parkinson's, and Alzheimer's were deregulated compared with NC samples.

![KEGG pathway hierarchical clustering trees.\
Pathways such as Huntington's disease, Parkinson's disease, oxidative phosphorylation, and carbon metabolism were significantly altered after knockdown of miR-21a-5p in the mouse model of spinal cord injury. KD: Knockdown; NC: negative control.](NRR-15-1102-g007){#F6}

Amyotrophic lateral sclerosis (ALS) is an untreatable and deadly disease that involves steady loss of motor neurons in different parts of the nervous system, such as the brain stem, cerebral cortex, and spinal cord (Ricci et al., 2018). Previously, Benigni et al. (2016) confirmed significant downregulation of miR-21a-5p in humans with ALS. We also found that in ALS, miR-21a-5p was downregulated (**[Figure 7](#F7){ref-type="fig"}**). Numerous reasons may underlie the gathering of neurofilaments in neurodegenerative diseases, such as proteolysis, mutations in neurofilaments, dysregulation of neurofilament gene expression, defective axonal transport and irregular posttranslational modifications. Neurofilament accumulation is also possible because of exposure to toxic agents (Perrot and Julien, 2010).

![Amyotrophic lateral sclerosis, pathway ID\# mmu05014.\
During amyotrophic lateral sclerosis, miR-21a-5p was downregulated at the mitochondrial level, as were all three main neurofilaments (light, medium and heavy), compared with the negative control group. Yellow boxes represent proteins in the knockdown group, while green represents proteins that were not present in our data. MiR-21a-5p can be used as a biomarker to more comprehensively understand and identify the pathogenesis of amyotrophic lateral sclerosis.](NRR-15-1102-g008){#F7}

During ALS, three neurofilaments (NefL, NefM, and NefH), which exist as polypeptides at the mitochondria level, are important for the radial development of axons during growth, stabilization of axon caliber, and communication of electrical impulses within axons (Yuan et al., 2012). These proteins were downregulated by miR-21a-5p KD compared with NC, which further confirms the possibility of its use as a disease biomarker. In addition, downregulation of miR-21a-5p is involved in the mitochondrial apoptotic pathway, which yields further insight into the processes responsible for motor neuron degradation (Laser-Azogui et al., 2015).

Discussion {#sec1-4}
==========

Proteomic approaches can provide new ways to understand the role of miR-21a-5p in various diseases. During this study, we found that many proteins upregulated in the KD group compared with the NC group play a key role in inflammatory regulation, response towards immunity, and antioxidant activity. Between KD and NC groups, there were 394 and 332 significant proteins, respectively. We identified significant proteins in each group on the bases of coverage and validated our results with western blot assays, which also indicated upregulated levels of some proteins, such as vimentin, compared with NC. Meanwhile, stathmin was downregulated in the KD group compared with the NC group. S100-A8 protein plays a role in tumor-stromal interactions and, in arthritis, acts as a pro-inflammatory factor. In humans, the simplest defense mechanism is inflammation. During this process, local and external toxic or dangerous materials are removed to safeguard the body. However, when this system disproportionately responds, for instance during extreme or long-term inflammation, tissue damage can occur. Several studies have confirmed that S100-A8 and S100-A9 proteins have significant importance in the expansion of inflammation and its maintenance (Wang et al., 2018a). In this study, comparative analysis revealed significant upregulation of S100-A8 (about two-fold) in the KD group compared with the NC group. Stathmin downregulation is reportedly necessary for macrophage activation (Patel et al., 2009; Lachkar et al., 2010; Xu and Harrison, 2015; Nouar et al., 2016). The results of this study showed stathmin downregulation with miR-21a-5p knockdown, indicating that macrophage activation contributed to the recovery of SCI.

Myelination is vital for quick and precise impulse transmission within the vertebrate nervous system, and the thickness of myelin is based on the size of the axon fiber (Michailov et al., 2004; Monk et al., 2015). Myelin sheaths are a significantly stretched and altered plasma membrane that enfold around the nerve axon in a helical style (Raine, 1984; Thurnherr et al., 2006; Benninger et al., 2007; Nodari et al., 2007). We found that the protein-protein interaction between unique proteins of the KD group, which were missing from the NC group, were associated with the myelin sheath. Moreover, proteins highly enriched in the KD group play a significant role in pathways such as Huntington's disease, Parkinson's disease, carbon metabolism, and oxidative phosphorylation. Neurofilaments, which are important for neuronal caliber, were downregulated in the KD group compared with the NC group.

ALS is a fatal neurological disease as a result of the death of voluntary muscles controlled by the neurons that degenerate (Robberecht and Philips, 2013). Approximately 90% of ALS is diagnosed as periodic (due to some accident, usually traffic- or sports-related), while the remaining 10% is genetically inherited (Renton et al., 2014; Paez-Colasante et al., 2015; Benigni et al., 2016; Morgan and Orrell, 2016). The key role of miR-21a-5p in ALS makes it a useful biomarker for further studies, especially as authenticated biomarkers for ALS are lacking and microRNAs are a modern molecular tool with significant connections to diseases such as ALS (Waller et al., 2017). Recently, the microRNA miR-218 was revealed to be a prospective biomarker for ALS (Hoye et al., 2017). As small non-coding RNA molecules (8--22 nucleotides), miRNAs control the expression of various genes at the post-transcriptional level in a situational manner (Viader et al., 2011; Kye and Goncalves Ido, 2014). Importantly, miRNAs are also convenient biomarkers because they are consistently found within body fluids (Saraiva et al., 2017).

This comparative study between two groups (KD and NC) provides an overall idea about the presence of significant differentially expressed proteins. However, differentially expressed proteins in KD and NC groups detected by MS were only partially verified. Moreover, the molecular mechanism by which miR-21-5p regulates these differentially expressed proteins is unclear; future experiments will be conducted to identify this mechanism. Although further studies are needed, our results support the potential utility of miR-21 as a biomarker for recovery of SCI, ALS, and other neurological diseases.
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